Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma

byKathleen Lau

February 5, 2021

in StudyGraphics

Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression

RelatedReports

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

March 20, 2023

$Proton radiotherapy may be effective for refractory pituitary adenomas$

Chronic Disease

Pituitary microadenomas exhibit slow growth and may require less frequent MRI surveillance

March 18, 2023

Nivolumab may be effective in platinum-resistant ovarian cancer

Gastroenterology

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

March 15, 2023

Study explores effects of daily iron supplementation in 2- to 5-year-olds

Chronic Disease

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

March 15, 2023

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

2 Minute Medicine Rewind February 8, 2021

Quick Take: Association of Cereal, Gluten, and Dietary Fiber Intake With Islet Autoimmunity and Type 1 Diabetes

Higher consumption of refined grains other than white rice associated with a greater mortality and cardiovascular disease risk

Type I diabetes not associated with early menopause [OVADIA study]

Māori and Pacific New Zealanders may be disproportionately affected by type 2 diabetes-related clinical outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

Pituitary microadenomas exhibit slow growth and may require less frequent MRI surveillance

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression

2 Minute Medicine Rewind February 8, 2021

RelatedReports

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

Pituitary microadenomas exhibit slow growth and may require less frequent MRI surveillance

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

2 Minute Medicine Rewind February 8, 2021

Higher consumption of refined grains other than white rice associated with a greater mortality and cardiovascular disease risk

Māori and Pacific New Zealanders may be disproportionately affected by type 2 diabetes-related clinical outcomes

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma

RELATED REPORTS

Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression

2 Minute Medicine Rewind February 8, 2021

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?